Group A streptococcus in children
Interim clinical guidance summary
9 December 2022
This interim clinical guidance update is aimed at clinicians involved in the diagnosis and treatment of children up to the age of 18 years, and follows the UKHSA report released on 2 December 2022. It was developed by the NHS England Group A Streptococcus Clinical Reference Group and UKHSA Incident Management Team. It is endorsed by Royal College of General Practitioners (RCGP), Royal Pharmaceutical Society (RPS), Royal College of Paediatrics and Child Health (RCPCH) and the National Institute for Health and Care Excellence (NICE).
This interim guidance is valid until end of January 2023 and will be reviewed with epidemiology of infections and emerging evidence.
The Welsh Medicines Information Centre has developed guidance on use of solid dosage forms in children, particularly to administer doses which are not a “full tablet/capsule” dose. They have also produced an accompanying patient information leaflet for parents and carers.